Skip to main content
SpringerLink
Log in

Enzymes in pancreatic islets that use NADP(H) as a cofactor including evidence for plasma membrane aldehyde reductase

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Recent evidence of a pyruvate malate shuttle capable of transporting a large amount of NADPH equivalents out of mitochondria in pancreatic islets suggests that cytosolic NADP(H) plays a role in beta cell metabolism. To obtain clues about these processes the activities of several NADPH‐utilizing enzymes were estimated in pancreatic islets. Low levels of pyrroquinolone quinone (PQQ) and low levels of enzyme activity that reduce PQQ were found in islets. Low activities of palmitoyl‐CoA and stearoyl‐CoA desaturases were also detected. Significant activities of glutathione reductase, aldose reductase (EC.1.1.1.21) and aldehyde reductase (EC.1.1.1.2) were present in islets. Potent inhibitors of aldehyde and aldose reductases inhibited neither glucose‐induced insulin release nor glucose metabolism in islets indicating that these reductases are not directly involved in glucose‐induced insulin reaction. Over 90% of aldose reductase plus aldehyde reductase enzyme activity was present in the cytosol. Kinetic and chromatographic studies indicated that 60–70% of this activity in cytosol was due to aldehyde reductase and the remainder due to aldose reductase. Aldehyde reductase‐like enzyme activity, as well as aldose reductase immunoreactivity, was detected in rat islet plasma membrane fractions purified by a polyethylene glycol‐Dextran gradient or by a sucrose gradient. This is interesting in view of the fact that voltage‐gated potassium channel beta subunits that contain aldehyde and aldose reductase‐like NADPH-binding motifs have been detected in plasma membrane fractions of islets [Receptors and Channels 7: 237–243, 2000] and suggests that NADPH might have a yet unknown function in regulating activity of these potassium channels. Reductases may be present in cytosol to protect the insulin cell from molecules that cause oxidative injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ashcroft SJH, Christie MR: Effect of glucose on the cytosolic ratio of reduced oxidized nicotinamide-adenine dinucleotide phosphate in rats islets of Langerhans. Biochem J 184: 697–700, 1979

    Google Scholar 

  2. Hedeskov CJ, Capito K, Thams P: Cytosolic ratios of free [NADPH]/ [NADP+] and [NADH]/[NAD+] in mouse pancreatic islets, and nutrient-induced insulin secretion. Biochem J 241: 161–167, 1987

    Google Scholar 

  3. Ammon HPT, Steinke J: 6-Amnionicotinamide (6-AN) as a diabetogenic agent. In vitro and in vivo studies in the rat. Diabetes 21: 143–148, 1972

    Google Scholar 

  4. MacDonald MJ, Ammon HPT, Patel TN, Steinke J: Failure of 6-aminonicotinamide to inhibit the potentiating effect of leucine and arginine on glucose-induced insulin release in vitro. Diabetologia 10: 761–765, 1974

    Google Scholar 

  5. MacDonald MJ: Feasibility of mitochondrial pyruvate malate shuttle in pancreatic islets. J Biol Chem 270: 20051–20058, 1995

    Google Scholar 

  6. Sener A, Malaisse-Lagae F, Dufrane S, Malaisse WF: The coupling of metabolic to secretatory events in pancreatic islets. Biochem J 220: 433–440, 1984

    Google Scholar 

  7. MacDonald MJ: Estimates of glycolysis, pyruvate (de)carboxylation, pentose phosphate pathway, and methyl succinate metabolism in incapacitated pancreatic islets. Arch Biochem Biophys 305: 205–214, 1993

    Google Scholar 

  8. Conget I, Rasschaert J, Sener A, Leclerk-Meyer V, Penacarrillo MV, Valverde I, Malaisse WJ: Secretory, biosynthetic, respiratory, cationic, and metabolic responses of pancreatic islets to palmitate and oleate. Biochem Med Metab Biol 51: 175–184, 1994

    Google Scholar 

  9. Varnotte C, Gilon P, Nenquin M, Henquin JC: Mechanisms of the stimulation of insulin release by saturated fatty acid, a study of palmitate effects in mouse B-cells. Diabetes 43: 703–711, 1994

    Google Scholar 

  10. Hicks EO, Taylor CI, Vij SK, Knopf RF Jr, Floyd JR, Fajans SS: Effects of changes in plasma levels of free fatty acids on plasma glucagon, insulin, and growth hormone in man. Metabolism 26: 1011–1023, 1977

    Google Scholar 

  11. Tamarit-Rodriguez J, Vara E, Tamarit J: Starvation-induced changes of palmitate metabolism and insulin secretion in isolated rat islets stimulated by glucose. Biochem J 221: 317–324, 1984

    Google Scholar 

  12. Ammon HPT, Grimm A, Lutz S, Wagner-Teschner D, Handel M, Hagenloh I: Islet glutathione and insulin release. Diabetes 29: 830–834, 1980

    Google Scholar 

  13. Ammon HPT, Mark M: Thiols and pancreatic beta-cell function: A review. Cell Biochem Funct 3: 157–171, 1985

    Google Scholar 

  14. Gilbert HF: Molecular and cellular aspects of thiol-disulfide exchange. Adv Enzymol 93: 69–172, 1990

    Google Scholar 

  15. Anjaneyulu K, Anjaneyulu R, Sener A, Malaisse WJ: The stimulussecretion coupling of glucose-induced insulin release. Thiol: Disulfide balance in pancreatic islets. Biochimie 64: 29–36, 1982

    Google Scholar 

  16. Gabbay KH: Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Ann Rev Med 26: 521–536, 1975

    Google Scholar 

  17. Dufrane SP, Malaisse WJ, Sener A: A micromethod for the assay of aldose reductase, its application to pancreatic islets. Biochem Med 32: 99–105, 1984

    Google Scholar 

  18. Gabbay KH, Tze WJ: Inhibition of glucose-induced release of insulin by aldose reductase inhibitors. Proc Natl Acad Sci USA 69: 1435–1439, 1972

    Google Scholar 

  19. Malaisse WJ, Sener A, Mahy M: The stimulus-secretion coupling of glucose-induced insulin release. Sorbitol metabolism in isolated islets. Eur J Biochem 47: 365–370, 1974

    Google Scholar 

  20. Nakayama K, Murakami N, Ohta M, Kato K, Notsu T, Mizota M, Miwa I, Okuda J: Effects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats. Eur J Pharmacol 276: 85–91, 1995

    Google Scholar 

  21. Lippmann W, Kobric M: Effect of alrestatin on arginine-induced secretion of glucagon and insulin in the rat. Horm Metab Res 10: 280–282, 1978

    Google Scholar 

  22. Chouinard SW, Wilson GF, Schlimgen AK, Ganetzky B: A potassium channel beta subunit related to the aldo-keto reductase superfamily is encoded by the Drosophila hyperkinetic locus. Proc Natl Acad Sci USA 92: 6763–6767, 1995

    Google Scholar 

  23. McCormack T, McCormack K: Shaker K+ channel beta subunits belong to an NAD(P)H-dependent oxidoreductase superfamily. Cell 79: 1133–1135, 1994

    Google Scholar 

  24. Chouinard SW, Lu F, Ganetzky B, MacDonald MJ: Evidence for voltage-gated potassium channel â-subunits with oxidoreductase motifs in human and rodent pancreatic beta cells. Receptors Channels 7: 237–243, 2000

    Google Scholar 

  25. Lacy PE, Kostianovsky M: Methods for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35–39, 1967

    Google Scholar 

  26. Scharp DW, Kemp CB, Knight MJ, Ballinger WF, Lacy PE: The use of Ficoll in the preparation of viable islets of Langerhans from the rat pancreas. Transplantation 16: 686–689, 1973

    Google Scholar 

  27. MacDonald MJ: Metabolism of the insulin secretagogue methyl succinate by pancreatic islets. Arch Biochem Biophys 300: 201–205, 1993

    Google Scholar 

  28. MacDonald MJ: Rapid inactivation of rat liver phosphoenolpyruvate carboxykinase by microsomes and reversal by reductants. Biochem Biophys Acta 615: 223–236, 1980

    Google Scholar 

  29. Rana RS, MacDonald MJ: Phosphatidylinositol kinase in rat pancreatic islets: Subcellular distribution and sensitivity to calcium. Horm Metab Res 18: 659–662, 1986

    Google Scholar 

  30. Ramanadham S, Hsu F, Bohrer A, Nowatzke W, Ma Z, Turk J: Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: Comparison to other tissues and implication for membrane fusion in insulin exocytosis. Biochemistry 37: 4553–4567, 1998

    Google Scholar 

  31. Morre DJ, Morre DM: Cell membrane techniques - part II: Preparation of mammalian plasma membranes by aqueous two-phase partition. Biotechniques 7: 946–958, 1989

    Google Scholar 

  32. Paz MA, Gallop PM, Torrelio BM, Fluckiger R: The amplified detection of free and bound methoxatin (PQQ) with nitroblue tetrazolium redox reactions: Insights into the PQQ-locus. Biochem Biophys Res Commun 154: 1330–1337, 1988

    Google Scholar 

  33. Xu F, Mack CP, Quandt KS, Slafer M, Hulquist DE: Pyrroquinoline quinone acts with flavin reductase to reduce ferryl myoglobin in vitro and protects isolated heart from re-oxygenation injury. Biochem Biophys Res Commun 193: 434–439, 1993

    Google Scholar 

  34. Sugioka K, Nakano M, Naito I, Tero-Kubata S, Ikegami Y: Properties of a coenzyme, pyrroquinoline quinone: Generation of an active oxygen species during a reduction-oxidation cycle in the presence of NAD(P)H and O2. Biochim Biophys Acta 964: 15–182, 1988

    Google Scholar 

  35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275, 1951

    Google Scholar 

  36. Xu F, Quandt KS, Hultquist DE: Characterization of NADPH-dependent methemoglobin reductase as a heme-binding protein present in erythrocytes and liver. Proc Natl Acad Sci USA 89: 2130–2134, 1992

    Google Scholar 

  37. Hulquist DE, Xu F, Quandt KS, Chlafer M, Mack DP, Till GO, Seekamp A, Betz AL, Ennix SR: Evidence that NADPH-dependent methemoglobin reductase and administered riboflavin protect tissues from oxidative injury. Am J Hematol 42: 13–18, 1993

    Google Scholar 

  38. Kumazawa T, Seno H, Urakami T, Matsumoto T, Suzuki O: Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectrometry. Biochim Biophys Acta 1156: 62–66, 1992

    Google Scholar 

  39. Steinberg FM, Gershwin ME, Rucker RB: Dietary pyrroloquinoline quinone: Growth and immune response in BALB/c mice. J Nutr 124: 744–753, 1994

    Google Scholar 

  40. MacDonald MJ: Quinone reductase enzyme activity in pancreatic islets. Endocrinology 129: 1370–1374, 1991

    Google Scholar 

  41. Bohren KM, Bullock B, Wermuth B, Gabbay KH: The aldo-keto reductase superfamily. J Biol Chem 264: 9547–9551, 1989

    Google Scholar 

  42. Vander Jagt DL, Hunsaker LA, Robinson B, Strangebye LA, Deck LM: Aldehyde and aldose reductases from human placenta. J Biol Chem 19: 10912–10918, 1990

    Google Scholar 

  43. Wermuth B, Burgisser H, Bohren K, Von Wartburg J: Purification and characterization of human-brain aldose reductase. Eur J Biochem 127: 279–284, 1982

    Google Scholar 

  44. Wermuth B, Von Wartburg J: Aldose reductase from human tissues. Meth Enzymol 89: 181–186, 1982

    Google Scholar 

  45. Hoffman PL, Wermuth B, Von Wartburg J: Human brain aldehyde reductases: Relationship to succinic semialdehyde reductase and aldose reductase. J Neurochem 35: 354–366, 1980

    Google Scholar 

  46. El-Kabbani O, Wilson DK, Petrash JM, Quiocho FA: Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites. Mol Vis 4: 19–25, 1998

    Google Scholar 

  47. El-Kabbani O, Old SE, Ginell SL, Carper DA: Aldose and aldehyde reductases: Structure-function studies on the coenzyme and inhibitorbinding sits. Mol Vis 5: 20–25, 1999

    Google Scholar 

  48. Jez JM, Flynn TG, Pennings TM: A new nomenclature for the aldoketo reductase superfamily. Biochem Pharmacol 54: 639–647, 1997

    Google Scholar 

  49. Kizer JS, Vargas-Cordon M, Brendel K, Bressler R: The in vitro inhibition of insulin secretion by diphenylhydantoin. J Clin Invest 49: 1942–1948, 1970

    Google Scholar 

  50. Levin SR, Grosky GM, Hagura R, Smith D: Comparison of the inhibitory effects of diphenylhydantoin and diazoxide upon insulin secretion from the isolated perfused pancreas. Diabetes 21: 856–862, 1972.

    Google Scholar 

  51. Pace CS, Livingston E: Ionic basic of phenytoin sodium inhibition of insulin secretion in pancreatic islets. Diabetes 28: 1077–1082, 1979

    Google Scholar 

  52. Matthews EK, Sakamoto Y: Pancreatic islet cells: Electrogenic and electrodiffusional control of membrane potential. J Physiol 246: 439–457, 1975

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Wisconsin, Childrens Diabetes Center, Madison, WI, 53706, USA

    Muriel Laclau, Feng Lu & Michael J. MacDonald

Authors
  1. Muriel Laclau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Feng Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael J. MacDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J. MacDonald.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laclau, M., Lu, F. & MacDonald, M.J. Enzymes in pancreatic islets that use NADP(H) as a cofactor including evidence for plasma membrane aldehyde reductase. Mol Cell Biochem 225, 151–160 (2001). https://doi.org/10.1023/A:1012238709063

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012238709063

Search

Navigation